Increasing product speed, agility and scale in the lab.
How pharma companies and industry leaders can reset for growth in the lab beyond coronavirus.
In the era of “fast-moving products” and digital disruption, pharma companies are battling with customer demand to deliver products to market at increased speed and scale.
With Covid-19 severely disrupting research and development (R&D) operations, pharma leaders need to ever-more prepare to safeguard patients and employees, adapt operations for recovery in a pandemic economy and deliver drugs to market quickly where these products are most needed.
Central to this mission is making significant investments to increase uses of digital technologies to truly digitization the value chain, from R&D through to commercialization, positively impacting drug discovery and delivering products to market on-time, at scale.
In this webinar we tackle some of the key challenges affecting manufacturing, data management and R&D in the lab.